Patents by Inventor David L. Wolfe

David L. Wolfe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240251252
    Abstract: Techniques for identifying one or more wireless access points (APs), from among a plurality of APs including 6 GHz radios, as candidates to operate in standard power indoor (SPI) mode. Identification includes determining, based on one or more wireless stations (STAs) associated with the one or more APs, that the one or more APs should operate in SPI mode as opposed to lower power indoor (LPI) mode. The one or more wireless APs are configured to operate in SPI mode.
    Type: Application
    Filed: April 5, 2024
    Publication date: July 25, 2024
    Inventors: Vishal S. DESAI, David L. WOLF
  • Patent number: 11979751
    Abstract: Techniques for identifying one or more wireless access points (APs), from among a plurality of APs including 6 GHz radios, as candidates to operate in standard power indoor (SPI) mode. Identification is based on at least one of: determining that network switches associated with the wireless APs meet a threshold requirement relating to power over ethernet (PoE) for operating in SPI mode, determining, based on at least one of radio frequency (RF) density and channel quality relating to the plurality of APs, that the one or more APs should operate in SPI mode as opposed to lower power indoor (LPI) mode, and determining that operating the one or more APs in SPI mode improves quality of service (QoS) metrics for the plurality of APs as opposed to operating the one or more APs in LPI mode. The one or more wireless APs are configured to operate in SPI mode.
    Type: Grant
    Filed: September 16, 2021
    Date of Patent: May 7, 2024
    Assignee: Cisco Technology, Inc.
    Inventors: Vishal S. Desai, David L. Wolf
  • Publication number: 20230082337
    Abstract: Techniques for identifying one or more wireless access points (APs), from among a plurality of APs including 6 GHz radios, as candidates to operate in standard power indoor (SPI) mode. Identification is based on at least one of: determining that network switches associated with the wireless APs meet a threshold requirement relating to power over ethernet (PoE) for operating in SPI mode, determining, based on at least one of radio frequency (RF) density and channel quality relating to the plurality of APs, that the one or more APs should operate in SPI mode as opposed to lower power indoor (LPI) mode, and determining that operating the one or more APs in SPI mode improves quality of service (QoS) metrics for the plurality of APs as opposed to operating the one or more APs in LPI mode. The one or more wireless APs are configured to operate in SPI mode.
    Type: Application
    Filed: September 16, 2021
    Publication date: March 16, 2023
    Inventors: Vishal S. DESAI, David L. WOLF
  • Publication number: 20040072757
    Abstract: Analogs of blood factors which are transiently inactive are useful in treatment of diseases characterized by thrombosis. In addition, modified forms of activated blood factors that generate the active blood factor in serum but have extended half-lives are useful in treating hemophilic conditions. These modified forms of the blood factor may be acylated forms which are slowly deacylated in vivo.
    Type: Application
    Filed: November 13, 2003
    Publication date: April 15, 2004
    Applicant: COR Therapeutics, Inc.
    Inventors: David L. Wolf, Uma Sinha
  • Patent number: 6117836
    Abstract: Reagents that specifically bind a carbohydrate target wherein sialic acid is linked at the nonreducing terminus of a glycoside to a galactose or galactosamine residue through an .alpha.2-6 linkage are able to inhibit the conversion of human Factor X to human Factor Xa. These reagents (SA/Gal/GalNAc binding reagents) as well as other strategies for inhibiting the conversion of Factor X to Factor Xa are useful in treating thrombosis, inflammation and other conditions associated with excess thrombin activity.
    Type: Grant
    Filed: December 2, 1994
    Date of Patent: September 12, 2000
    Assignee: COR Therapeutics, Inc.
    Inventors: Uma Sinha, David L. Wolf
  • Patent number: 5990079
    Abstract: Analogs of blood factors which are transiently inactive are useful in treatment of diseases characterized by thrombosis. In addition, modified forms of activated blood factors that generate the active blood factor in serum but have extended half-lives are useful in treating hemophilia conditions. These modified forms of the blood factor may be acylated forms which are slowly deacylated in vivo.
    Type: Grant
    Filed: January 30, 1998
    Date of Patent: November 23, 1999
    Assignee: COR Therapeutics Inc.
    Inventors: David L. Wolf, Uma Sinha
  • Patent number: 5968897
    Abstract: Analogs of blood factors which are transiently inactive are useful in treatment of diseases characterized by thrombosis. In addition, modified forms of activated blood factors that generate the active blood factor in serum but have extended half-lives are useful in treating hemophilic conditions. These modified forms of the blood factor may be acylated forms which are slowly deacylated in vivo.
    Type: Grant
    Filed: January 30, 1998
    Date of Patent: October 19, 1999
    Assignee: COR Therapeutics, Inc.
    Inventors: David L. Wolf, Uma Sinha
  • Patent number: 5837679
    Abstract: Analogs of blood factors which are transiently inactive are useful in treatment of diseases characterized by thrombosis. In addition, modified forms of activated blood factors that generate the active blood factor in serum but have extended half-lives are useful in treating hemophilic conditions. These modified forms of the blood factor may be acylated forms which are slowly deacylated in vivo.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: November 17, 1998
    Assignee: COR Therapeutics, Inc.
    Inventors: David L. Wolf, Uma Sinha
  • Patent number: 5798332
    Abstract: Reagents that specifically bind a carbohydrate target wherein sialic acid is linked at the nonreducing terminus of a glycoside to a galactose or galactosamine residue through an .alpha.2-6 linkage are able to inhibit the conversion of human Factor X to human Factor Xa. These reagents (SA/Gal/GalNAc binding reagents) as well as other strategies for inhibiting the conversion of Factor X to Factor Xa are useful in treating thrombosis, inflammation and other conditions associated with excess thrombin activity.
    Type: Grant
    Filed: September 6, 1994
    Date of Patent: August 25, 1998
    Assignee: COR Therapeutics, Inc.
    Inventors: Uma Sinha, David L. Wolf
  • Patent number: 5583107
    Abstract: Analogs of blood factors which are transiently inactive are useful in treatment of diseases characterized by thrombosis. In addition, modified forms of activated blood factors that generate the active blood factor in serum but have extended half-lives are useful in treating hemophilic conditions. These modified forms of the blood factor may be acylated forms which are slowly deacylated in vivo.
    Type: Grant
    Filed: June 29, 1994
    Date of Patent: December 10, 1996
    Assignee: COR Therapeutics, Inc.
    Inventors: David L. Wolf, Uma Sinha
  • Patent number: 5496724
    Abstract: An assay for screening snake venom for the presence or absence of platelet aggregation inhibitors (PAIs) based on specific receptor binding is described. Using this assay, the identification and characterization of PAIs in a wide range of snake venom samples was accomplished. The isolated and purified PAI from several of these active snake venoms is described and characterized. In addition, PAIs lacking the Arg-Gly-Asp (RGD) adhesion sequence but containing K*-(G/Sar)-D wherein K* is a modified lysyl residue of the formulaR.sup.1.sub.2 N(CH.sub.2).sub.4 CHNHCO--wherein each R.sup.1 is independently H, alkyl(1-6C) or at most one R.sup.1 is R.sup.2 --C.dbd.NR.sup.3 wherein R.sup.2 is H, alkyl(1-6C) or is NR.sup.4.sub.2 in which each R.sup.4 is independently H or alkyl(1-6C) and R.sup.3 is H, alkyl(1-6C), phenyl or benzyl, or R.sup.2 --C.dbd.NR.sup.3 is a radical selected from the group consisting of: ##STR1## where m is an integer of 2-3, and each R.sup.
    Type: Grant
    Filed: May 24, 1993
    Date of Patent: March 5, 1996
    Assignee: COR Therapeutics, Inc.
    Inventors: Robert M. Scarborough, David L. Wolf, Israel F. Charo
  • Patent number: 5449483
    Abstract: Making a tire mold by spraying molten atomized metal on a model to form a metal shell and then reinforcing the shell with a resin backing to form a mold segment for the tire mold. Modular shoe container assemblies have replaceable backing members for making different size molds and flat plate spacers for providing different thicknesses of the mold segment. In one embodiment a slide block is used for one side of the cavity whereby a sole plate is eliminated.
    Type: Grant
    Filed: February 4, 1994
    Date of Patent: September 12, 1995
    Assignee: The Goodyear Tire & Rubber Company
    Inventors: Alan Greenwood, Paul T. Hardy, Veronique Moris-Herbeuval, Werner Hillman, Norbert Majerus, Douglas E. Pryor, Timothy M. Rooney, Ronda R. Bayer-Thayer, David L. Wolfe
  • Patent number: 5318899
    Abstract: An assay for screening snake venom for the presence or absence of platelet aggregation inhibitors (PAIs) based on specific receptor binding is described. Using this assay, the identification and characterization of PAIs in a wide range of snake venom samples was accomplished. The isolated and purified PAI from several of these active snake venoms is described and characterized. In addition, PAIs lacking the Arg-Gly-Asp (RGD) adhesion sequence but containing K.sup.* -(G/Sar)-D wherein K.sup.* is a modified lysyl residue of the formulaR.sup.1.sub.2 N(CH.sub.2).sub.4 CHNHCO--wherein each R.sup.1 is independently H, alkyl(1-6C) or at most one R.sup.1 is R.sup.2 --C.dbd.NR.sup.3 wherein R.sup.2 is H, alkyl(1-6C) or is NR.sup.4.sub.2 in which each R.sup.4 is independently H or alkyl(1-6C) and R.sup.3 is H, alkyl(1-6C), phenyl or benzyl, or R.sup.2 --C=NR.sup.3 is a radical selected from the group consisting of: ##STR1## where m is an integer of 2-3, and each R.sup.
    Type: Grant
    Filed: February 20, 1990
    Date of Patent: June 7, 1994
    Assignee: COR Therapeutics, Inc.
    Inventors: Robert M. Scarborough, David L. Wolf, Israel F. Charo
  • Patent number: 4975476
    Abstract: A composition useful as a pavement material comprising a mixture of asphalt and a polymer of an .alpha.-olefin, or an interpolymer of an .alpha.-olefin, and at least one copolymer selected from the group consisting of an .alpha., .beta.-unsaturated carboxylic acid, a monomer of an .alpha.,.beta.-unsaturated carboxylic acid, a vinyl ester of alkanoic acid, and carbon monoxide.
    Type: Grant
    Filed: January 25, 1990
    Date of Patent: December 4, 1990
    Assignee: The Dow Chemical Company
    Inventor: David L. Wolfe
  • Patent number: 4933384
    Abstract: A composition useful as a pavement material comprising a mixture of asphalt and a polymer of an .alpha.-olefin, or an interpolymer of an .alpha.-olefin, and at least one copolymer selected from the group consisting of an .alpha.,.beta.-unsaturated carboxylic acid, a monomer of an .alpha.,.beta.-unsaturated carboxylic acid, a vinyl ester of alkanoic acid, and carbon monoxide.
    Type: Grant
    Filed: January 10, 1986
    Date of Patent: June 12, 1990
    Assignee: The Dow Chemical Company
    Inventor: David L. Wolfe
  • Patent number: 4839404
    Abstract: A composition useful as a pavement material comprising a mixture of asphalt, aggregate and an interpolymer of an .alpha.-olefin monomer selected from the group consisting of an .alpha.,.beta.-ethylenically unsaturated carboxylic acid or an ionomer of an .alpha.,.beta.-ethylenically unsaturated carboxylic acid.
    Type: Grant
    Filed: July 28, 1986
    Date of Patent: June 13, 1989
    Assignee: The Dow Chemical Company
    Inventors: Dane Chang, David L. Wolfe
  • Patent number: 4709538
    Abstract: A machine for feeding a collapsed beverage can carrier sleeve to a flight bar conveyor and introducing the sleeve in fully open condition to the pocket of the conveyor. After leaving the feed rolls the collapsed carrier sleeve is moved through a fixed guide by lugs on a movable chain. The end flaps on the upwardly facing side panel are held in place on the guide while the end flaps on the downwardly facing side panel are moved downwardly by a fixed cam surface. The substantially opened sleeve is then either given a final kick by rotating arms or is propelled by the feed lugs to accelerate it into the pocket while at the same time fully straightening and opening the sleeve. The carton dimension corresponding to the length of the pocket is the same as the length of the pocket, resulting in more pockets per conveyor length and permitting operation at slower conveyor speeds.
    Type: Grant
    Filed: May 9, 1986
    Date of Patent: December 1, 1987
    Assignee: Manville Corporation
    Inventors: Peter C. Olsen, Jr., Peter M. Conforto, Jimmy R. Craighead, David L. Wolf
  • Patent number: 4693055
    Abstract: A machine for feeding beverage cans to open-ended carrier sleeves of varying capacities. When loading relatively small carrier sleeves, inboard conveyors and associated metering screws feed groups of cans to a flight bar conveyor which moves the groups through the open ends of the carrier sleeves. When loading relatively large carrier sleeves, outboard conveyors and associated metering screws are also operated after first replacing the inboard screws with screws able to separate cans into larger groups, the same size as those formed by the outboard screws. This arrangement feeds larger groups of cans which are then fed to the larger carrier sleeves. In one embodiment each conveyor comprises a longer upstream conveyor and a shorter downstream conveyor spaced a short distance therefrom to allow the flight bars to travel through the space between the conveyors when moving from the end of their upward run to the beginning of their horizontal downstream run.
    Type: Grant
    Filed: October 6, 1986
    Date of Patent: September 15, 1987
    Assignee: Manville Corporation
    Inventors: Peter C. Olsen, Jr., Peter M. Conforto, David L. Wolf, Donald R. Hudson
  • Patent number: 4671046
    Abstract: An apparatus and method for squaring up the sides of a bulk shipping container and for forming a paperboard cover over and securing it to the upper end of the container.
    Type: Grant
    Filed: July 3, 1986
    Date of Patent: June 9, 1987
    Assignee: Container Corporation of America
    Inventors: D. Michael Lewis, David L. Wolf, Ray L. Russell
  • Patent number: 4568076
    Abstract: A device for automatically feeding, one at a time, relatively thin, flat articles, such as paperboard sheets or knocked down boxes, from the top of the stack of articles positioned on an elevating mechanism.
    Type: Grant
    Filed: August 15, 1984
    Date of Patent: February 4, 1986
    Assignee: Container Corporation of America
    Inventors: D. Michael Lewis, David L. Wolf